CLASS-SPECIFIC RHEUMATOID FACTORS IN JUVENILE CHRONIC ARTHRITIS. CLINICAL ASSOCIATIONS by Varbanova, B.
Scripta Scientifica Medica, vol. 30(1998), pp. 115-122 
Copyright © Medical University, Varna 
CLASS-SPECIFIC RHEUMATOID FACTORS IN JUVENILE 
CHRONIC ARTHRITIS. CLINICAL ASSOCIATIONS 
* B. Varbanova 
Department of Paediatrics, Medical University of Varna, Varna 
The study aimed at determining the prevalence of the class-specific rheumatoid 
factors (RFs) in juvenile chronic arthritis (JCA) and evaluating the diagnostic test quali-
ties. A total of JCA 79 patients (48 with pauciarticular form, 17 of whom with extending 
pauciarthritis), 31 with polyarticular for, as well as 125 control children (58 healthy and 67 
disease controls) were tested. Most JCA patients (95%) had negative Waaler-Rose test. 
ELISAfor the detection of IgM-, IgA- and IgG- isotypes of RFs was used. The diagnostic 
characteristics of the tests were evaluated by clinico-epidemiological methods (assessment 
of sensitivity, specificity, positive predictive value, and likelihood ratio). The prevalence of 
IgG-, IgA- and IgM-RF in JCA versus all controls at optimal cut offtitres was 16 %, 22 c/c 
and 32%, respectively. The test for IgG-RF was not diagnostically significant. IgA-RF had 
the highest prevalence in the polyarticular form (40 %). The diagnostic qualities of the test 
were significant, mostly concerning the differentiation of the polyarticular course of JCA 
and the presence of erosive arthritis. IgM-RF was most typical of the polyarticular form ( 
55 %) followed by the extending pauciarthritis (41 %). The diagnostic test qualities were 
significant and most prominent to distinguish the polyarticular course and erosive arthri-
tis. IgM- and IgA-RFs had significant diagnostic value in JCA, mainly for the polyarticular 
and extending pauciarticular form and also in regard to more severe disease course. IgG-
RF had no diagnostic significance for JCA. 
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Juvenile chronic arthritis ( J C A ) 
is a heterogeneous disease that encom-
passes different forms defined by the 
type of onset. There is evidence sup-
ported by immunogenetic studies that 
the various subgroups may represent 
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distinct disease entities (1,2). Numer-
ous immunological abnormalities have 
been detected in J C A , but the most char-
acteristic serological findings are A N A 
and IgM-rheumatoid factor thought to 
be useful in patients' classification and 
management. Antinuclear antibodies 
are most commonly found in children 
with early onset pauciarthritis and late 
onset seropositive polyarthritis (1-3). In 
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contrast, the IgM-rheumatoid factor 
measured by conventional agglutination 
techniques, is a hallmark only of a pol­
yarthritis with late onset resembling 
adult rheumatoid arthritits. This group 
of patients with "seropositive4' disease 
represent less than 20 % of all J C A chil­
dren. Using more sensitive techniques, 
it has already been established that rheu­
matoid arthritis ( R A ) patients' sera con­
tain not only the "classical" 19S IgM-
R F , but also other isotypes of rheuma­
toid factor ( R F ) . Lots of studies have 
emphasized the presence of IgG-, IgA-
, IgM- and even I g E - R F in patients with 
"seronegative" R A (4-6). 
The aim of this study is to de­
termine the prevalence and to attempt 
to evaluate the diagnostic and prognos­
tic qualities of the E L I S А-tests for rheu­
matoid factor isotypes in polyarticular 
and pauciarticular forms at onset of J C A 
and compare them. 
M A T E R I A L A N D M E T H O D S 
Patients 
We studied serum samples from 
204 children. Seventy-nine of them ful­
filled the EULAR-cr i t e r i a for J C A and 
were classified by subgroup onset types 
as followed: 48 with pauciarticular dis­
ease (17 of whom with extending 
pauciarticular disease) and 31 with pol­
yart icular form. The patients' age 
ranged from 1,5 to 18 years. They had 
active disease for at least one year be­
fore the sampling and most of them (82 
% ) were having active disease at the 
time of study. A l l patients were taking 
N A S A I D s and/or slow-acting antirheu­
matic drugs. Agglutination test for 19S 
IgM-RF by Waaler-Rose was positive 
in 4 cases (5 % ) . Fifty patients had non-
erosive and 29 had erosive arthritis. One 
hundred and twenty five control chil­
dren were tested simultaneously - 58 
healthy controls ranging in age from 2 
to 14 years and 67 patients (22 with S L E 
and 45 with other inflammatory and 
autoimmune diseases). 
Methods 
Clinical evaluation of the im­
munologic findings was made in regard 
to the following clinical criteria: form 
of the disease, disease activity and ra­
diological progression. 
The following immunological 
methods were used: 
1) IgM-RF E L I S A assay (devel­
oped in CLB-Amsterdam). In brief, flat-
bottomed 96-wel l microtitre plates 
( M A X I SORP, N U N C ) were coated 
with 150 1 25 g human gamma globu­
lin/ml in P B S overnight. After wash­
ing with 0,1 % Tween 20 in P B S , 100 1 
serum 1/100 diluted in P B S was added 
and incubated for 2 hours at 37C. After 
washing, 100 1 conjugated mouse anti-
human IgM to H R P O diluted in P B S 
0,1 %Tween 20 was incubated for 2 
hours in 37C. After washing 100 1 sub­
strate (OPD/H2O2) was incubated for 
10-20 min. The reaction was stopped 
by 5N H2SO4. Absorption was mea­
sured by Dynatech reader at 492 nm. 
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W H O rheumatoid factor standard was 
used (kindly provided by H . G . M . 
Geertzen from CLB-Amsterdam). In 
each plate a control pool of sera from 
negative healthy children was tested 
simultaneously. As positive results were 
considered those exceeding 12,5 I U , 
weak positive - between 6,25 and 12,5 
I U , and negative results - below 6,25. 
2) lgG- and I g M - R F E L I S A assay (de-
veloped in Immunology Lab of The Na-
tional Centre of Allergology-Sofia). The 
methods differed from those for IgM-
R F at the following points: 1) rabbit IgG 
was used as antigen; 2) the upper limits 
for IgG-RF and I g A - R F were defined 
based on the mean value of the healthy 
control population plus 2 SD. 
The statistical and epidemio-
logical methods included variation 
analysis, t- statistics. Fisher's exact test 
and test characteristics for diagnostic 
significance as defined by the clinical 
epidemiology methods (7,8) (sensitiv-
ity, specificity, positive predictive value 
and likelihood ratio). 
R E S U L T S A N D D I S C U S S I O N 
The mean values of the differ-
ent R F isotypes in the control groups 
and J C A and their upper limits are 
shown in Table 1. 
The prevalence of IgG-, IgA-
and I g M - R F in J C A and subgroups are 
presented in Table 2. 
Table 1 




(mean value ± SD) 
Upper limits for 
control sera (x ± 2 SD) 
JCA patients 
(mean value ± SD) 
IgG 0,16 ±0,069 0,30 0,18 ±0,09 
IgA 0,17 ±0,089 0,35 0,23 ±0,14 
IgM below 3 IU 6,25 IU 6.45 IU 
Table 2 
Prevalence of IgG, IgA and IgM-RFs in JCA and subgroups compared to controls 
Isotype healthy control JCA-total non-extending extending pauciarticular polyarticular 
controls patients pauciarthritis pauciarthritis form total form 
n=58 n=67 % n=79 % n=31 % n=17 % n=48 % n=31 % 
IgG-RF - 8/67 12% 13/79 16%* 7/31 23% 1/17 6 % 4/48 17 % 5/31 16% 
IgA-RF - 4/67 6% 17/78 22%* 2/31 6% 3/17 18% 5/48 10%) v 12/30 40% * • 
IgM-RF - 3/67 4% 18/55 33%* 1/21 5% 5/12 42% *# 6/33 8% A 12/22 55%*# 
? p=0.024 compared to control group 
*p< 0.001 compared to controls 
#p< 0.001, ? p-0.02 compared to non-extending pauciarticular form 
? p-0.0028 and ? p-0.009 compared to polyarticular form 
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The mean values of IgG-RF in 
J C A and control groups did not signifi­
cantly differ from one another. There 
were no healthy children expressing 
IgG-RF. Increased antibody levels were 
found in 12 % of the control patients. 
Similar prevalence was observed in the 
J C A group where in 13/79 ( 1 6 % ) IgG-
R F was detected. Diagnostic character­
istics of the test were not significant for 
J C A (Table 3). 
No significant clinical associa­
tions were established in J C A patients 
(F ig . l ) . 
Table 3 
Diagnostic characteristics of the ELlSA-tests for IgG-, IgA- and IgM-RFs 
Diagnostic characteristics JCA/controls polyarticular form non- extending extending 
pauciarthritis pauciarthntis 
Isotype t L u. Urn E L 
oc QC ОС oc CC 0C ОС oc oc oc 
6 < 6 < 6 < 6 < S 
Mi 
Sensitivity 0.17 0.22 0.33 0.16 0.4 0.55 0.23 0.06 0.05 0.06 0.18 0.42 
Specificity 0.95 0.97 0.97 0.95 0.97 0.97 0.95 0.97 0.97 0.95 0.97 0.97 
Positive predictive value 0.62 0.81 0.83 0.38 0.75 0.79 0.47 0.33 0.53 0.11 0.50 0.64 
Likelihood ratio 3.4 8.0 11.0 3.2 13.3 18.3 4.6 2.0 2.0 1.2 6.0 14 
Fig. 1. Clinical associations of class-specific RFs 
The mean value of I g A - R F in 
J C A was found to be higher as com­
pared to healthy children (p < 0,001) 
and disease controls (p = 0,007). IgA-
R F was not observed in healthy chil­
dren and was present in 6 % of those 
from the disease control group only. 
Positive I g A - R F was established in 17/ 
79 (22 % ) of J C A patients. This preva­
lence was significantly higher when 
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compared to the controls. The highest 
prevalence of I g A - R F was registered in 
the polyarticular group 12/30 (40 % ) 
fo l lowed by the extending 
pauciarticular 3/17 (33 % ) and non-ex­
tending pauciarticular form 2/31 (6 % ) . 
Significant difference was also found 
between the pauciarticular and pol­
yarticular form; non-exetending and 
extending pauciartritis. Diagnostic 
characteristics of the test are presented 
on Table. 3. I g A - R F showed an asso­
ciation with polyarticular form and ero­
sive disease (Fig. 1). 
IgM-RF was not detected in the healthy 
children (< 6,25 IU) . In the disease con­
trol group there were low positive test 
results (6,25-12,5 ILJ) in 3 patients (4 
% ) but a borderline line result of 6,25 
UI - in one patient only. The mean value 
of the IgM-RF in J C A was increased as 
compared to the healthy children (p < 
0,001) and disease controls (p = 0,014). 
The majority of positive patients ex­
pressed weak positive levels of IgM-
R F (6,25-12,5 IU) and only 6/18 (33 % ) 
patients all having polyarthritis showed 
positive levels exceeding 12,5 I U . The 
prevalence of IgM-RF in J C A was 18/ 
55 (32 % ) , i . е., significantly higher than 
that in the control group. 
Regarding the distribution of 
the positive results in J C A we found 
that the majority of positive patients had 
polyarthritis 12/55 (22 % ) , 5/55 (9 % ) 
had extending pauciarticular, and 1/55 
(2 % ) - non-extending pauciarthritis. A l l 
proportions were significantly distin­
guished from each other - polyarthritis 
vs non-extending pauciarthritis (p < 
0 ,001) , polyarthri t is vs extending 
pauciarthritis (p = 0,014), and extend­
ing pauciarthritis vs non-extending one 
(p = 0,029). On analyzing the preva­
lence of I g M - R F in the disease sub­
groups, we established that the antibody 
was present in 12/22 (55 % ) of the pa­
tients with polyarthritis, in 5/12 (42 % ) 
of those with extending pauciarticular 
disease and in 1/21 (5 % ) of the patients 
with non-extending pauciarthritis. 
There was a significant difference of the 
prevalence of IgM-RF in the polyarticu­
lar form as compared to the control 
group, non-extending pauciartritis and 
extending one. Extending pauciarthritis 
prevalence was higher when compared 
to the controls and non-extending 
pauciarticular disease. Diagnostic char­
acteristics of the test for IgM-RF we 
demonstrated on Table 3. C l in i ca l 
evaluation of the findings revealed an 
association of IgM-RF with polyarticu­
lar dosease and erosive arthritis (Fig. 
1). Eleven of 20 positive patients (55 
% ) expressed more than one R F isotype. 
Classical 19S IgM-RF is an in­
dicator of erosive arthritis and serologi­
cal marker for the late-onset polyarticu­
lar J C A (less than 20 % of the disease 
population). The presence of this anti­
body in younger patients and such with 
other forms is unusual (2,9). Over the 
last 15 years a lot of studies have dem­
onstrated that "seronegative" patients 
with R A and J C A express different 
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isotypes of R F in their sera (6,10-14). 
Moreover, Moore et al . established 
"hidden" IgM-RF in the immune com­
plexes of sera from J C A children cor­
relating with the disease activity (1,4). 
In our study we found IgG-, IgA- and 
IgM-RF in the sera of "seronegative" 
patients with J C A . Our results showed 
that the prevalence of I g G - R F was not 
significantly higher than that of the con­
trols. Approximately the same preva­
lence was observed in the S L E patients 
(14 % ) . Epidemiological patterns of di­
agnostic value of this test were insig­
nificant. No significant clinical associa­
tions were found, These results corre­
spond to other studies (11,12,15,16) 
which have reported a prevalence of 
I g G - R F ranging from 4 to 8 % with no 
clinical significance. In our study low 
I g A - R F levels were demonstrated in the 
J C A patients with a significant preva­
lence of 22 % as compared to the con­
trols. The highest prevalence of 40 % 
was observed in the polyarticular group 
where the highest antibody levels were 
detected. The extending pauciarthritis 
showed a lower prevalence than the 
polyarticular form but a significantly 
higher one than the non-extending 
pauciarthritis. According to the epide­
miological characteristics, I g A - R F had 
diagnostic value mainly for the pol­
yarticular J C A . We also found that IgA-
R F correlated with erosive arthritis, 
which indicates a more severe disease. 
I g A - R F was reported to be a highly spe­
cific marker for disease activity and 
severity in R A (5,17,18) with recently 
confirmed diagnostic significance (19). 
Walker et al. (20) demonstrated IgA-RF 
in 58 % of the J C A patients with pol­
yarthritis, strongly correlating with the 
disease activity, whereas the antibody 
was absent in the pauciarticular and 
systemic form. In contrast, Saulsbury 
(9) observed the highest prevalence of 
Ig A-RF in the pauciarticular form. 
We found I g M - R F in 1/3 of the 
patients with J C A which was signifi­
cantly higher as compared to the con­
trols. The WHO-standard enabled us to 
quantify the test results precisely. No 
positive results were yielded in the 
group of healthy controls and the ma­
jority of them (95 %) had levels below 
the maximal dilution of the standard « 3 
I U ) . Only 4 % of the disease controls 
had low IgM-RF levels (6,25-12,5 I U ) 
and two of them were S L E patients. The 
remainder had insignificant levels 
mostly below 3 I U . An impressive dif­
ference was observed between the 
prevalence of IgM-RF in the subgroups. 
J C A patients with polyarticular disease 
expressed significantly higher IgM-RF 
levels than the controls. Polyarticular 
and extending pauciarthritis showed a 
higher prevalence than non-extending 
pauci-arthritis. These findings suggest 
that the term "seronegativity" in J C A 
needs to be discussed. The results also 
indicate that RF-positivity is not obliga­
tory linked to the late-onset polyarticu­
lar form. Our data also suggest that the 
extending pauciarticular form is an en-
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tity which is clearly distinguished from 
that with non-extending oligoarticular 
onset and course of the disease. Forty-
two per cent of these patients had IgM-
R F and 1/5 of them - I g A - R F . A l l of 
them had more than two relapses of the 
disease, duration over 3 years and the 
majority had active disease at the time 
of the investigation. It might be more 
appropriate to refer the extending 
pauciarthritis to the polyarticular sub­
group considering the course of the dis­
ease rather than the type of onset. The 
diagnostic characteristics of the IgM-
R F test are significant. It could be used 
in the diagnosing the J C A and distin­
guishing the polyarticular disease, in 
particular, since after the test the likeli­
hood for diagnosing the polyarticular 
J C A increases 18-fold and for the ex­
tending pauciartritis - 14-fold. We also 
prove that I g M - R F is a marker for dis­
ease severity, since a significant corre­
lation with erosive disease has been 
found. However, according to our find­
ings, I g M - R F is not dependent on dis­
ease activity. 
In conclusion, we consider that 
J C A patients express IgG-, IgA- and 
IgM-RFs as measured by E L I S A . IgA-
and IgM-RFs. ELISA-tes ts have a di­
agnostic significance and could be an 
alternative for the agglutination assays 
in seronegative patients with polyarticu­
lar disease. I g A - R F and I g M - R F are 
serological markers for disease sever­
ity and radiological progression of J C A . 
Extended clinical study wil l enable us 
to assess the real clinical importance of 
these data. 
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К л а с - с п е ц и ф и ч н и р е в м а т о и д н и ф а к т о р и п р и б о л н и 
с ю в е н и л е н х р о н и ч е н а р т р и т 
Б. Върбанова 
Катедра по педиатрия, Медицински университет-Варна 
Резюме: Целта на проучването е да сс изследват болните с ювенилен хроничен артрит 
(ЮХА) за наличие на различни изотипове ревматоидни фактори (RFs) с E L I S A и се 
определи диагностичната значимост на тестовете. Изследвани са 87 деца с различни 
форми на ЮХА - 48 с олигоартритна форма (31 с неразширен и 17 - с разширен 
олигоартрит), 31 с полиартритна и 8 със системна форма на заболяването. С 
изключение на 4 деца, всички останали са с негативен тест на Waaler-Rose. Резултатите 
са сравнявани с контролни групи - 58 здрави и 67 деца с ревматолофгични и 
автоимунни заболявания. Ние установихме несигнификантно превалиране на ниски 
титри IgG-RF при 17% от болните и намираме, че тестът няма необходимите 
диагностични качества при ЮХА. IgA-RF откриваме при 22 % от децата с ЮХА, 
предимно такива с полиартритна форма (40 % ) , като разликата с изследваните 
контроли е статистически достоверна. Тестът има диагностични възможности за 
диференциране на болните с полиартикуларен ход на заболяването и ерозивен артрит. 
IgM-RF е установен при 33 % от децата с ЮХА. Превалирането му е различно при 
отделните форми, но с най-голяма честота се среща при полиартритната форма (55 
% ) и разширената олигоартритна форма (41 % ) . Тестът притежава много добри 
диагностични качества за диференциране на болните с полиартикуларен ход на ЮХА 
и ерозивен артрит. Доказването на клас-специфични ревматоидни фактори при ЮХА 
подлага на съмнение серонегативната природа на заболяването и дава обяснение на 
причината за по-тежко протичане и неблагоприятна прогноза при някои от болните. 
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